Research Topics
| Bernard BransonSummaryAffiliation: Centers for Disease Control and Prevention Country: USA Publications
| Collaborators
|
Detail Information
Publications
2012 HIV Diagnostics Conference: the molecular diagnostics perspectiveBernard M Branson
CDC Division of HIV AIDS Prevention, 1600 Clifton Road MS D 21, Atlanta, GA 30333, USA
Expert Rev Mol Diagn 13:243-5. 2013....
Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settingsBernard M Branson
Division of HIV AIDS Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention proposed, Atlanta, GA 30333, USA
MMWR Recomm Rep 55:1-17; quiz CE1-4. 2006..Repeat screening in the third trimester is recommended in certain jurisdictions with elevated rates of HIV infection among pregnant women...- Current HIV epidemiology and revised recommendations for HIV testing in health-care settingsBernard Branson
Division of HIV AIDS Prevention, CDC, Atlanta, Georgia 30333, USA
J Med Virol 79:S6-10. 2007..The CDC issued the revised recommendations on September 22, 2006, and is now engaged with numerous professional organizations on practical strategies for implementation... - State of the art for diagnosis of HIV infectionBernard M Branson
Division of HIV AIDS Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Clin Infect Dis 45:S221-5. 2007..These new testing technologies offer unique opportunities to diagnose HIV infection among the estimated 252,000-312,000 persons in the United States who are currently unaware they are infected... - The future of HIV testingBernard M Branson
Division of HIV AIDS Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
J Acquir Immune Defic Syndr 55:S102-5. 2010.... - Sexually transmitted diseases treatment guidelines, 2010Kimberly A Workowski
Division of STD Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Atlanta, GA 30333, USA
MMWR Recomm Rep 59:1-110. 2010.... 
Cost-effectiveness of pooled nucleic acid amplification testing for acute HIV infection after third-generation HIV antibody screening and rapid testing in the United States: a comparison of three public health settingsAngela B Hutchinson
Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
PLoS Med 7:e1000342. 2010..However, cost-effectiveness analyses to guide policy around AHI screening are lacking; particularly after more sensitive third-generation antibody screening and rapid testing...- Performance of an oral fluid rapid HIV-1/2 test: experience from four CDC studiesKevin P Delaney
Division of HIV AIDS Prevention Surveillance and Epidemiology, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
AIDS 20:1655-60. 2006..To evaluate the performance of a rapid HIV antibody test used with whole blood and oral fluid in settings where the test is likely to be used... - Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom useBeens Varghese
Division of HIV AIDS Prevention Surveillance and Epidemiology, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Sex Transm Dis 29:38-43. 2002..Sexual acquisition of HIV is influenced by choice of partner, sex act, and condom use. However, current risk-reduction strategies focus mainly on condom use... - Assessment of BED HIV-1 incidence assay in seroconverter cohorts: effect of individuals with long-term infection and importance of stable incidenceJanet M McNicholl
Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
PLoS ONE 6:e14748. 2011..We sought to assess its performance in three longitudinal cohorts from Thailand where HIV-1 CRF01_AE and subtype B' dominate the epidemic... - Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassayJ Steven McDougal
Division of HIV AIDS Prevention, National Center for HIV AIDS, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
AIDS Res Hum Retroviruses 22:945-52. 2006..Cross-sectional HIV incidence estimation circumvents many of the drawbacks associated with longitudinal cohort studies, but there are test-specific limitations that should be considered in the design of population surveys... - Detecting unsuspected HIV infection with a rapid whole-blood HIV test in an urban emergency departmentSheryl B Lyss
National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
J Acquir Immune Defic Syndr 44:435-42. 2007..To evaluate and compare HIV screening and provider-referred diagnostic testing as strategies for detecting undiagnosed HIV infection in an urban emergency department (ED)... - Investigation of false positive results with an oral fluid rapid HIV-1/2 antibody testKrishna Jafa
Division of HIV AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
PLoS ONE 2:e185. 2007..From August 2004-June 2005, we investigated a sudden increase in false-positive results occurring in a performance study of OraQuick oral-fluid rapid HIV tests in Minnesota... - Comparing the costs of HIV screening strategies and technologies in health-care settingsPaul G Farnham
Division of HIV AIDS Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, MS E 48, Atlanta, GA 30333, USA
Public Health Rep 123:51-62. 2008..The purpose of this research was to estimate the costs of these different testing procedures and the cost per HIV-infected patient correctly receiving test results in three health-care scenarios that illustrated these policy differences... - A meta-analysis of the effectiveness of alternative HIV counseling and testing methods to increase knowledge of HIV statusAngela B Hutchinson
Division of HIV AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30306, USA
AIDS 20:1597-604. 2006..Alternatives to conventional HIV counseling and testing (HIV-CT) have been used to improve receipt of HIV test results... - Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countriesJ Steven McDougal
National Center for HIV AIDS, STD, TB Prevention, Centers for Disease Control and Prevention, US Public Health Service, Atlanta, GA 30333, USA
AIDS 19:S25-30. 2005.... - FDA approves OraQuick for use in saliva. On March 25, the FDA approved the first rapid test for HIV in oral fluidsBernard M Branson
Laboratory Determinants and Diagnostics Section, Division of HIV/AIDS Prevention, CDC, USA
AIDS Clin Care 16:39. 2004 - Rapid HIV-1 testing during labor: a multicenter studyMarc Bulterys
Division of HIV AIDS Prevention, Surveillance and Epidemiology, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
JAMA 292:219-23. 2004..Timely testing of women in labor with undocumented human immunodeficiency virus (HIV) status could enable immediate provision of antiretroviral prophylaxis... - Cost comparison of three HIV counseling and testing technologiesDonatus U Ekwueme
Division of HIV AIDS Prevention Intervention Research and Support, Centers for Disease Control and Prevention, 4700 Buford Highway N E, Atlanta, GA 30341, USA
Am J Prev Med 25:112-21. 2003..New rapid-testing technologies may improve receipt of results, but no study has systematically analyzed the costs of these newer technologies compared with the standard protocol... - Evaluation of the performance characteristics of 6 rapid HIV antibody testsKevin P Delaney
Division of HIV AIDS Prevention Surveillance and Epidemiology, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, USA
Clin Infect Dis 52:257-63. 2011..Since 2002, the US Food and Drug Administration has approved 6 rapid human immunodeficiency virus (HIV) tests for use in the United States. To date, there has been no direct comparison of the performance of all 6 tests... - Standardization and monitoring of laboratory performance and quality assurance by use of the less-sensitive HIV incidence assay: seven years of resultsJoanne V Mei
Division of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, GA, USA
J Acquir Immune Defic Syndr 58:482-8. 2011..We report on the performance of the assay using proficiency testing and quality control materials tested from 2001 to 2008... - Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypesBharat S Parekh
Division of Global AIDS Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
AIDS Res Hum Retroviruses 27:265-73. 2011..The determination of ω with more data and new methodology suggests that ω of the BED-CEIA varies between different subtypes and/or populations. These estimates for ω may affect incidence estimates in various studies... - Evaluation of an ultrasensitive p24 antigen assay as a potential alternative to human immunodeficiency virus type 1 RNA viral load assay in resource-limited settingsRichard A Respess
Global AIDS Program, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd, Mail stop A 12, Atlanta, GA 30333, USA
J Clin Microbiol 43:506-8. 2005..4% at a viral load of <30,000 (232 specimens from 65 seropositive subjects). The assay was highly reproducible, with excellent correlation between duplicates and among three laboratories... - Do physicians provide counseling with HIV and STD testing at physician offices or hospital outpatient departments?Guoyu Tao
Division of STD Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
AIDS 17:1243-7. 2003.... - Performance of the OraQuick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapyRobert J O'Connell
Department of Infectious Diseases, Wilford Hall Medical Center, Lackland Air Force Base, Texas 78236, USA
J Clin Microbiol 41:2153-5. 2003..Four false-negative subjects, who were characterized by early initiation of effective antiretroviral therapy, demonstrated waning serum anti-gp41 titers and Western blot band intensities... - Overcoming barriers to HIV testing: preferences for new strategies among clients of a needle exchange, a sexually transmitted disease clinic, and sex venues for men who have sex with menFreya Spielberg
University of Washington, Seattle, WA, USA
J Acquir Immune Defic Syndr 32:318-27. 2003..To determine strategies to overcome barriers to HIV testing among persons at risk... - Designing an HIV counseling and testing program for bathhouses: the Seattle experience with strategies to improve acceptabilityFreya Spielberg
Department of Family Medicine, Center for AIDS and STDs, University of Washington, Seattle, USA
J Homosex 44:203-20. 2003..Use of FDA approved, new rapid tests that do not require venipuncture, centrifugation, or laboratory oversight will further decrease barriers to testing and facilitate implementation of bathhouse testing programs in other communities... - Opt-out testing for human immunodeficiency virus in the United States: progress and challengesJohn G Bartlett
Johns Hopkins University School of Medicine, 1830 E Monument St, Room 447, Baltimore, MD 21205, USA
JAMA 300:945-51. 2008.... - Virological evaluation of the 'Ottawa case' indicates no evidence for HIV-1 superinfectionJonathan B Angel
Ottawa Health Research Institute and The Ottawa Hospital, University of Ottawa, Ottawa, Canada
AIDS 18:331-4. 2004..Whether HIV-1 superinfection contributes to disease progression or the spread of drug-resistant HIV-1 remains unknown... - Incidence immunoassay for distinguishing recent from established HIV-1 infection in therapy-naive populationsKim M Wilson
National Serology Reference Laboratory, St Vincent s Institute, Melbourne, Australia
AIDS 18:2253-9. 2004..To identify a specific marker of recent HIV-1 infection... - To screen or not to screen: is that really the question?Bernard M Branson
Ann Intern Med 145:857-9. 2006 - Outcomes of offering rapid point-of-care HIV testing in a sexually transmitted disease clinicSabrina R Kendrick
Department of Medicine, The Ruth M. Rothstein CORE Center, Chicago, IL 60612, USA
J Acquir Immune Defic Syndr 38:142-6. 2005..CONCLUSION: Rapid HIV testing was acceptable and feasible in this STD clinic and facilitated entry of newly identified HIV-infected patients into health care... - Choosing HIV Counseling and Testing Strategies for Outreach Settings: A Randomized TrialFreya Spielberg
University of Washington, Seattle, WA, USA
J Acquir Immune Defic Syndr 38:348-55. 2005..In surveys, clients have expressed preferences for alternatives to traditional HIV counseling and testing. Few data exist to document how offering such alternatives affects acceptance of HIV testing and receipt of test results... - Rapid HIV testing. Wait time reduced from days to minutesPatrick A Keenan
Department of Family Medicine and Community Health, University of Minnesota Medical School, Twin Cities, Minneapolis, USA
Postgrad Med 117:47-52. 2005..In this article, Drs Keenan, Keenan, and Branson discuss the advantages and limitations of rapid HIV testing in various settings... - Rapid HIV antibody testing in the New York State Anonymous HIV Counseling and Testing Program: experience from the fieldMara San Antonio-Gaddy
New York State Department of Health AIDS Institute, Corning Tower Rm 315, Albany, NY 12237, USA
J Acquir Immune Defic Syndr 43:446-50. 2006..To assess rapid and conventional HIV test use, client satisfaction, and counselors' comfort...